Legend Biotech
Focus: Legend Biotech is a cell therapy-focused biotechnology company headquartered in Piscataway, NJ, specializing in CAR-T and engineered T-cell immunotherapies for hematologic malignancies and solid tumors.
Profile data last refreshed 7h ago · AI intelligence enriched 1w ago
Open Jobs
69+1 this month
Stable — net +1 jobs in 30d
51 added, 50 removed. Backfill posture.
Should You Work at Legend Biotech?
AI assessmentLegend Biotech suits early-stage cell therapy specialists seeking high-risk/high-reward exposure to multiple clinical programs, but offers limited near-term commercial or financial upside for those prioritizing stability.
Why Work Here
- Pioneering cell therapy platform with 30 active programs spanning multiple modalities (CAR-T, NK cells, dual-specificity constructs) offering deep technical expertise opportunities
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
39 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LCAR-M61S cells preparation
Relapsed/Refractory Multiple MyelomaClinical Trials (1)
NCT06472479LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma
N/AHelp build intelligence for Legend Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.